MoseleyT.A.HaudenschildD.R.RoseL.ReddiA.H., 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155.
2.
ArenaA.EnzoB.EnricoG.MarcoB.GraziellaR., 2003. Specific immunotheraphy of allergic diseases: A three years perspective observational study. Int. J. Immunopathol. Pharmacol.16:277.
3.
HuangM.BerryJ.KandereK.LytinasM.KaralisK.TheoharidesT.C., 2002. Mast cell deficient w/wv mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol.15:249.
4.
MastrangeloG.FornasaC. VellerPavanelloS.MarcerG.LazzaroM.MilanG.FaddaE.FedeliU.ClonferoE., 2003. Polyaromatic hydrocarbons administered in humans by dermal route increase total IgE. Int. J. Immunopathol. Pharmacol.16:145.
5.
MadoniniE.AgostinisF.BarraR.BerraA.DonadioD.PappacodaA.StefaniE.TiernoE., 2003. Long-term and preventive effects of sublingual allergen-specific immunotherapy: A retrospective, multicentric study. Int. J. Immunopathol. Pharmacol.16:73.
6.
ChiappiniE.PeruzziM.GalliL.CalabriG.de MartinoM., 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with anticonvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol.15:239.
7.
VecchietJ.DalessandroM.TravasiF.FalascaK.Di IorioA.SchiavoneC.ZingarielloP.Di IlioE.PizzigalloE., 2003. Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int. J. Immunopathol. Pharmacol.16:157.
8.
KasaharaS.WagoH.CooperE.L., 2002. Dissociation of innate and adaptive immunity by UVB irradiation. Int. J. Immunopathol. Pharmacol.15:1.
9.
AlexandrakisM.G.KyriakouD.S.SeretakisD.BoucherW.LetourneauR.KempurajD.TheoharidesT.C., 2003. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1). Int. J. Immunopathol. Pharmacol.16:43.
10.
KempurajD.FrydasS.KandereK.MadhappanB.LetourneauR.ChristodoulouS.BoucherW.RiccioniG.ContiP.TheoharidesT.C., 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol.16:95.
11.
HurstS.D.MuchamuelT.GormanD.M.GilbertJ.M.CliffordT.KwanS.MenonS.SeymourB.JacksonC.KungT.T.BrielandJK.ZurawskiS.M.ChapmanRW.ZurawskiG.CoffmanR.L., 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25. J. Immunol.169:443.
12.
AarvakT.ChabaudM.MiossecP.NatvigJ.B., 1999. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol.162:1246.
13.
AlbanesiC.ScarponiC.CavaniA.FedericiM.NasorriF.GirolomoniG., 2000. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol.115:81.
14.
VernaN.CavallucciE.Di StefanoF.RamondoS.PaoliniF.CarusoR.GranaM.MarianoM.SchiavoneC.PaganelliR.Di GioacchinoM., 2002. Cyclosporin-A in allergic diseases. Int. J. Immunopathol. Pharmacol.15 (S):29.
15.
StarnesT.BroxmeyerH.E.RobertsonM.J.HromasR., 2002. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol.169:642.
16.
YoshinoS.HayashiH.TanedaS.TakanoH.SagaiM.MoriY., 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol.15:13.
17.
ArenaA.EnzoB.EnricoG.MarcoB.GraziellaR., 2003. Specific immunotheraphy of allergic diseases: A three years perspective observational study. Int. J. Immunopathol. Pharmacol.16:277.
18.
PerisK.FargnoliM. C.MordentiC.ChimentiM. SoleChimentiS., 2002. Cyclosporin-A for treatment of psoriasis. Int. J. Immunopathol. Pharmacol.15 (S):35.
19.
DemidovaT.N.HamblinM.R., 2004. Targeted photodynamic therapy to inflammatory cells and pathogens. Int. J. Immunopathol. Pharmacol.17:117.
20.
Appert-CollinA.DuongF.H.T.Passilly-DegraceP.GiesJ.-P.WarterJ.-M.PoindronP., 2004. Quantification of neurotrophin mRNA expression in PMN mouse: Modulation by Xaliproden. Int. J. Immunopathol. Pharmacol.17:157.
21.
PannelliniT.IezziM.Di CarloE.EleuterioE.ColettiA.ModestiA.RosiniS.NeriM.MusianiP., 2004. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int. J. Immunopathol. Pharmacol.17:171.
22.
BellussiL.MarcucciF.SensiL.G.PassaliG.C.LaurielloM.PassaliF.M.GiannuzziA.L.PassaliD., 2004. Do tryptase, ECP and specific IgE measurement by nasal incubation increase the specific nasal provocation test sensitivity?Int. J. Immunopathol. Pharmacol.17:201.
23.
MarchisioM.GrimleyP.M.Di BaldassarreA.SantavenereE.MisciaS., 2004. Novel shift of Jak/Stat signaling characterizes the protective effects of aurintricarboxylic acid (ATA) from tumor necrosis factor-α toxicity in human B lymphocytes. Int. J. Immunopathol. Pharmacol.17:5.
24.
Sodin-SemrlS.SpagnoloA.BarbaroB.VargaJ.FioreS., 2004. Lipoxin A4 counteracts interleukin-1β and transforming growth factor-β2 synergistic pro-inflammatory activation of human fibroblast-like synoviocytes. Int. J. Immunopathol. Pharmacol.17:15.
25.
BattistoniA.AjelloM.AmmendolaS.SupertiF.RotilioG.ValentiP., 2004. Involvement of reactive oxygen species in bacterial killing within epithelial cells. Int. J. Immunopathol. Pharmacol.17:71.
26.
KempurajD.FrydasS.ContiP.KandereK.BoucherW.LetourneauR.MadhappanB.HuangS.H.KoreakiS.ChristodoulouS.TheoharidesT.C., 2003. Interleukin-25: A new IL-17 family member with growth factor/inflammatory action. Int. J. Immunopathol. Pharmacol.16:185.
27.
TrubianiO.SalvoliniE.StaffolaniR.Di PrimioR.MazzantiL., 2003. DMSO modifies structural and functional properties of RPMI-8402 cells by promoting programmed cell death. Int. J. Immunopathol. Pharmacol.16:253